Karyopharm Therapeutics Inc.
KPTI
$1.61
-$0.09-5.03%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -28.34% | 42.52% | 38.95% | -11.26% | -26.08% |
| Total Receivables | 27.89% | -10.78% | -17.88% | -3.20% | -6.56% |
| Inventory | 10.98% | -10.87% | 1.82% | -20.55% | 4.68% |
| Prepaid Expenses | -13.12% | -7.17% | 14.45% | -2.70% | -19.80% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -15.80% | 22.48% | 14.93% | -8.30% | -18.60% |
|
|
|||||
| Total Current Assets | -15.80% | 22.48% | 14.93% | -8.30% | -18.60% |
| Net Property, Plant & Equipment | -3.24% | -3.27% | -3.12% | -9.82% | -8.17% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.17% | -5.50% | -63.30% | 0.00% | 0.60% |
| Total Assets | -15.29% | 21.22% | 12.66% | -8.24% | -17.88% |
|
|
|||||
| Total Accounts Payable | 79.01% | 6.89% | -25.76% | 107.62% | -55.77% |
| Total Accrued Expenses | 3.28% | 18.30% | -2.76% | 5.40% | 10.07% |
| Short-term Debt | -- | -- | -- | -98.98% | 0.10% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 24.44% | 51.28% | 63.75% | 75.84% | 723.41% |
| Total Finance Division Other Current Liabilities | 84.27% | 119.62% | -10.48% | 12.21% | -18.92% |
| Total Other Current Liabilities | 84.27% | 119.62% | -10.48% | 12.21% | -18.92% |
| Total Current Liabilities | 14.43% | 27.42% | 5.63% | -12.15% | 9.79% |
|
|
|||||
| Total Current Liabilities | 14.43% | 27.42% | 5.63% | -12.15% | 9.79% |
| Long-Term Debt | 6.61% | -4.93% | 11.18% | 10.85% | -1.13% |
| Short-term Debt | -- | -- | -- | -98.98% | 0.10% |
| Capital Leases | -5.21% | -4.79% | -4.41% | -3.89% | -3.61% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 105.09% | -61.29% | 14.64% | 75.42% | 49.71% |
| Total Liabilities | 11.19% | -1.07% | 9.81% | 6.31% | 3.06% |
|
|
|||||
| Common Stock & APIC | 0.17% | 3.39% | 5.63% | 0.20% | 0.30% |
| Retained Earnings | -3.76% | -1.27% | -6.17% | -2.04% | -2.35% |
| Treasury Stock & Other | -4.65% | -39.44% | 127.41% | -3.19% | 21.81% |
| Total Common Equity | -24.29% | 9.31% | -8.79% | -12.70% | -16.05% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -24.29% | 9.31% | -8.79% | -12.70% | -16.05% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -24.29% | 9.31% | -8.79% | -12.70% | -16.05% |
|
|
|||||